St. Louis, MO, United States of America

Sun-Ji Park

This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sun-Ji Park. Retrieved from https://idiyas.com/inventor/sun-ji-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sun-Ji Park: Innovator in Kidney Disease Treatment

Introduction

Sun-Ji Park is a notable inventor based in St. Louis, MO (US). She has made significant contributions to the field of medical research, particularly in the treatment of kidney diseases. Her innovative work focuses on addressing endoplasmic reticulum (ER) stress-mediated kidney diseases.

Latest Patents

Sun-Ji Park holds a patent for "Compositions and methods for treating and preventing endoplasmic reticulum (ER) stress-mediated kidney diseases." This patent outlines methods and compositions aimed at treating or preventing ER stress-mediated kidney diseases in subjects. The method involves administering a pharmaceutical composition that includes a therapeutically effective amount of an ER calcium channel stabilizing agent or an ER stress modulating agent, such as mesencephalic astrocyte-derived neurotrophic factor (MANF) or compound K201. She has 1 patent to her name.

Career Highlights

Sun-Ji Park is affiliated with Washington University, where she conducts her research. Her work has garnered attention for its potential impact on treating kidney diseases, which affect millions of individuals worldwide.

Collaborations

She collaborates with esteemed colleagues, including Ying Chen and Fumihiko Urano, to advance her research and develop effective treatments.

Conclusion

Sun-Ji Park's innovative contributions to the field of kidney disease treatment highlight her dedication to improving patient outcomes. Her research continues to pave the way for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…